# The Deep Sedation for Ablation Study

> **NCT03844841** · PHASE4 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 160 (actual)

## Conditions studied

- Atrial Fibrillation
- Ablation
- Sedation
- Propofol
- Dexmedetomidine

## Interventions

- **DRUG:** Propofol
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT03844841
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03844841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03844841, "The Deep Sedation for Ablation Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03844841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*